Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Advertise

© 2020 MJH Life Sciences and Drug Topics. All rights reserved.

Spotlight

Cardiovascular Clinical Consult
Diabetes
Generics
Gut Health
Immunization
Oncology
Respiratory
Shingles
Technology

ClinicalSee All >

Anticoagulants
Autoimmune Diseases
Biosimilars
Cardiovascular Disease
CBD
COPD Management
Coronavirus
Dermatology
Diabetes
Generics
Gut Health
Immunization
Influenza
Oncology
Pain Management
Pediatrics
Respiratory
Shingles

Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Advertise

© 2020 MJH Life Sciences and Drug Topics. All rights reserved.

Phase IV filgrastim study shows drug lives up to expectations

September 1, 2003

Amgen's filgrastim delivers what it promises in a phase IV study